Tumor necrosis factor alpha – Tumor necrosis factor receptor complex (TNF-α–TNFR complex) (TNF-α–TNFR complex)

The Tumor necrosis factor alpha – Tumor necrosis factor receptor (TNF-α–TNFR) complex is a pivotal protein-protein assembly that mediates essential pro-inflammatory signaling pathways within the immune system (UniProt P01375, P19438). TNF-α, primarily produced by activated macrophages, functions as a homotrimeric ligand that binds to its cognate receptors, TNFR1 and TNFR2, to trigger downstream effects such as NF-κB activation, apoptosis, and cytokine production (PubMed PMC2631033). This complex is a central driver of the inflammatory cascade, and its overactivity is implicated in the pathogenesis of various autoimmune diseases, including rheumatoid arthritis, Crohn's disease, and psoriasis (StatPearls NBK482425). Pharmacological intervention typically involves the use of biologics, such as monoclonal antibodies or decoy receptors, which prevent the formation of the complex by sequestering TNF-α (NIH/NCBI Bookshelf). By inhibiting this interaction, these drugs effectively reduce systemic inflammation and tissue damage in patients with chronic inflammatory conditions (StatPearls NBK482425). However, because the complex is also vital for host defense against pathogens, its therapeutic blockade carries risks of serious infections and potential malignancy (FDA Label - Humira). The complex also plays a role in regulating cell survival and death, making it a target of interest in oncology and infectious disease research (PubMed PMC2631033).

Other names

TNF-TNFR complexTNF-TNFR1 complexTNF-TNFR2 complexCachectin-TNFR complexTNFSF2-TNFRSF1 complexTumor necrosis factor ligand superfamily member 2 – Tumor necrosis factor receptor superfamily member 1A complex

Neutralization of soluble and membrane-bound TNF-α to prevent binding to TNFR1 and TNFR2, thereby inhibiting pro-inflammatory signaling cascades (StatPearls NBK482425).